Mesenteric lymph node cells from neonates present a prominent IL-12 response to CpG oligodeoxynucleotide via an IL-15 feedback loop of amplification

Veterinary Research

Volumn 42, Issue 1, 2011, Pages

  Ferret Bernard, Stéphanie ^a,b   Lacroix Lamandé, Sonia ^a   Remot, Aude ^a   Metton, Coralie ^a   Bernardet, Nelly ^a   Charley, Bernard ^c   Drouet, Françoise ^a   Laurent, Fabrice ^a  

^a UR1282   (France)

^b CEMAGREF   (France)

^c INRA Institut National de la Recherche Agronomique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

OVIS ARIES;

COLISTIN; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 15; LIGAND; OLIGODEOXYRIBONUCLEOTIDE; RNA; TOLL LIKE RECEPTOR;

AGE; ANIMAL; ANIMAL DISEASE; ARTICLE; BIOSYNTHESIS; COLOSTRUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; LYMPH NODE; METABOLISM; NEWBORN; POLYMERASE CHAIN REACTION; SHEEP; SPLEEN; TRANSMISSION ELECTRON MICROSCOPY;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; COLISTIN; COLOSTRUM; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; INTERLEUKIN-12; INTERLEUKIN-15; LIGANDS; LYMPH NODES; MICROSCOPY, ELECTRON, TRANSMISSION; OLIGODEOXYRIBONUCLEOTIDES; POLYMERASE CHAIN REACTION; RNA; SHEEP; SPLEEN; TOLL-LIKE RECEPTORS;

EID: 80051985499     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/1297-9716-42-19     Document Type: Article

References (42)

1. Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells. Levy O, Suter EE, Miller RL, Wessels MR, Blood 2006 108 1284 1290 10.1182/blood-2005-12-4821 16638933 (Pubitemid 44232026)
2. Hyper innate responses in neonates lead to increased morbidity and mortality after infection. Zhao J, Kim KD, Yang X, Auh S, Fu YX, Tang H, Proc Natl Acad Sci USA 2008 105 7528 7533 10.1073/pnas.0800152105 18490660 (Pubitemid 351830052)
3. Bovine neonate natural killer cells are fully functional and highly responsive to interleukin-15 and to NKp46 receptor stimulation. Elhmouzi-Younes J, Storset AK, Boysen P, Laurent F, Drouet F, Vet Res 2009 40 54 10.1051/vetres/2009037 19549488
4. Neonate intestinal immune response to CpG oligodeoxynucleotide stimulation. Lacroix-Lamandé S, Rochereau N, Mancassola R, Barrier M, Clauzon A, Laurent F, PLoS One 2009 4 8291 20011519
5. CpG motifs in bacterial DNA and their immune effects. Krieg AM, Annu Rev Immunol 2002 20 709 760 10.1146/annurev.immunol.20.100301.064842 11861616 (Pubitemid 34293438)
6. Oral and intraperitoneal administration of phosphorothioate oligodeoxynucleotides leads to control of Cryptosporidium parvum infection in neonatal mice. Barrier M, Lacroix-Lamandé S, Mancassola R, Auray G, Bernardet N, Chaussé AM, Uematsu S, Akira S, Laurent F, J Infect Dis 2006 193 1400 1407 10.1086/503748 16619188 (Pubitemid 43673388)
7. Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: the extent of gamma interferon modulation determines the outcome of infection. Theodos CM, Sullivan KL, Griffiths JK, Tzipori S, Infect Immun 1997 65 4761 4769 9353062 (Pubitemid 27463254)
8. Role of gamma interferon in chemokine expression in the ileum of mice and in a murine intestinal epithelial cell line after Cryptosporidium parvum infection. Lacroix-Lamandé S, Mancassola R, Naciri M, Laurent F, Infect Immun 2002 70 2090 2099 11895975 (Pubitemid 34242212)
9. Safety of CpG oligodeoxynucleotides in veterinary species. Ioannou XP, Griebel P, Mena A, Gomis SM, Godson DL, Mutwiri G, Hecker R, Babiuk LA, van Drunen Littel-van den Hurk S, Antisense Nucleic Acid Drug Dev 2003 13 157 167 10.1089/108729003768247628 12954116
10. Biological activity of immunostimulatory CpG DNA motifs in domestic animals. Mutwiri G, Pontarollo R, Babiuk S, Griebel P, van Drunen Littel-van den Hurk S, Mena A, Tsang C, Alcon V, Nichani A, Ioannou X, Gomis S, Townsend H, Hecker R, Potter A, Babiuk LA, Vet Immunol Immunopathol 2003 91 89 103 10.1016/S0165-2427(02)00246-5 12543546 (Pubitemid 36113256)
11. Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosis. Wedlock DN, Skinner MA, de Lisle GW, Vordermeier HM, Hewinson RG, Hecker R, an Drunen Littel-van den Hurk S, Babiuk LA, Buddle BM, Vet Immunol Immunopathol 2005 106 53 63 15910992 (Pubitemid 40720157)
12. CpG-ODN enhances mammary gland defense during mastitis induced by Escherichia coli infection in goats. Zhu YM, Miao JF, Zhang YS, Li Z, Zou SX, Deng YE, Vet Immunol Immunopathol 2007 120 168 176 10.1016/j.vetimm.2007.08.003 17869348 (Pubitemid 47632817)
13. Immunostimulatory CpG oligodeoxynucleotides enhance the induction of bovine CD4+ cytotoxic T-lymphocyte responses against the polymorphic immunodominant molecule of the protozoan parasite Theileria parva. Graham SP, Saya R, Awino E, Ngugi D, Nyanjui JK, Hecker R, Taracha EL, Nene V, Vet Immunol Immunopathol 2007 115 383 389 10.1016/j.vetimm.2006.11.010 17197038 (Pubitemid 46109057)
14. Formulation with CpG oligodeoxynucleotides increases cellular immunity and protection induced by vaccination of calves with formalin-inactivated bovine respiratory syncytial virus. Mapletoft JW, Oumouna M, Townsend HG, Gomis S, Babiuk LA, van Drunen Littel-van den Hurk S, Virology 2006 353 316 233 10.1016/j.virol.2006.06.001 16828832 (Pubitemid 44397136)
15. Stimulation of innate immune responses by CpG oligodeoxynucleotide in newborn lambs can reduce bovine herpesvirus-1 shedding. Nichani AK, Mena A, Kaushik RS, Mutwiri GK, Townsend HG, Hecker R, Krieg AM, Babiuk LA, Griebel PJ, Oligonucleotides 2006 16 58 67 10.1089/oli.2006.16.58 16584295
16. Of mice and men: species variations of Toll-like receptor expression. Rehli M, Trends Immunol 2002 23 375 378 10.1016/S1471-4906(02)02259-7 12133792 (Pubitemid 34804626)
17. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Edwards AD, Diebold SS, Slack EM, Tomizawa H, Hemmi H, Kaisho T, Akira S, Reise Sousa C, Eur J Immunol 2003 33 827 833 10.1002/eji.200323797 12672047 (Pubitemid 36546669)
18. TOLL-like receptors linking innate and adaptive immune response. Werling D, Jungi TW, Vet Immunol Immunopathol 2003 91 1 12 10.1016/S0165-2427(02)00228-3 12507844 (Pubitemid 36042793)
19. Neonatal goats display a stronger TH1-type cytokine response to TLR ligands than adults. Tourais-Esteves I, Bernardet N, Lacroix-Lamande S, Ferret-Bernard S, Laurent F, Dev Comp Immunol 2008 32 1231 1241 10.1016/j.dci.2008.03.011 18514862
20. Variability in cytokine production and cell proliferation by mitogen-activated ovine peripheral blood mononuclear cells: modulation by interleukin (IL)-10 and IL-12. Wattegedera S, Sills K, Howard CJ, Hope JC, McInnes CJ, Entrican G, Vet Immunol Immunopathol 2004 102 67 76 10.1016/j.vetimm.2004.06.006 15451616 (Pubitemid 39296964)
21. Identification of monoclonal antibodies that cross-react with cytokines from different animal species. Pedersen LG, Castelruiz Y, Jacobsen S, Aasted B, Vet Immunol Immunopathol 2002 88 111 122 10.1016/S0165-2427(02)00139-3 12127410 (Pubitemid 34786753)
22. Development of an ELISA for bovine IL-10. Kwong LS, Hope JC, Thom ML, Sopp P, Duggan S, Bembridge GP, Howard CJ, Vet Immunol Immunopathol 2002 85 213 223 10.1016/S0165-2427(02)00007-7 11943322 (Pubitemid 34275434)
23. Interferon response in pigs: molecular and biological aspects. La Bonnardière C, Lefèvre F, Charley B, Vet Immunol Immunopathol 1994 43 29 36 7856060 (Pubitemid 24327525)
24. Migratory monocytes and granulocytes are major lymphatic carriers of Salmonella from tissue to draining lymph node. Bonneau M, Epardaud M, Payot F, Niborski V, Thoulouze MI, Bernex F, Charley B, Riffault S, Guilloteau LA, Schwartz-Cornil I, J Leukoc Biol 2006 79 268 276 10.1189/jlb.0605288 16330534 (Pubitemid 44831158)
25. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Bouskra D, Brézillon C, Bérard M, Werts C, Varona R, Boneca IG, Eberl G, Nature 2008 456 507 510 10.1038/nature07450 18987631 (Pubitemid 352759006)
26. Pulmonary dendritic cells isolated from neonatal and adult ovine lung tissue. Fach SJ, Brockmeier SL, Hobbs LA, Lehmkuhl HD, Sacco RE, Vet Immunol Immunopathol 2006 112 171 182 10.1016/j.vetimm.2006.02.012 16621027 (Pubitemid 43975145)
27. Two populations of ovine bone marrow-derived dendritic cells can be generated with recombinant GM-CSF and separated on CD11b expression. Foulon E, Foucras G, J Immunol Methods 2008 339 1 10 10.1016/j.jim.2008.07.012 18718839
28. A novel regulatory B-cell population in sheep Peyer's patches spontaneously secretes IL-10 and downregulates TLR9-induced IFNalpha responses. Booth JS, Griebel PJ, Babiuk LA, Mutwiri GK, Mucosal Immunol 2009 2 265 275 10.1038/mi.2009.6 19262501
29. Type I interferons and IL-12: convergence and cross-regulation among mediators of cellular immunity. Byrnes AA, Ma X, Cuomo P, Park K, Wahl L, Wolf SF, Zhou H, Trinchieri G, Karp CL, Eur J Immunol 2001 31 2026 2034 10.1002/1521-4141(200107)31:7<2026::AID-IMMU2026>3.0.CO;2-U 11449355 (Pubitemid 32640718)
30. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. Gautier G, Humbert M, Deauvieau F, Scuiller M, Hiscott J, Bates EE, Trinchieri G, Caux C, Garrone P, J Exp Med 2005 201 1435 1446 10.1084/jem.20041964 15851485 (Pubitemid 40664087)
31. Plasmacytoid dendritic cells: the key to CpG. Rothenfusser S, Tuma E, Endres S, Hartmann G, Hum Immunol 2002 63 1111 1119 10.1016/S0198-8859(02)00749- 8 12480254 (Pubitemid 36025985)
32. Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation. Kuwajima S, Sato T, Ishida K, Tada H, Tezuka HTO, Nat Immunol 2006 7 740 746 10.1038/ni1348 16715101 (Pubitemid 43905873)
33. Use of CpG oligodeoxynucleotides as immunoprotective agents. Klinman DM, Expert Opin Biol Ther 2004 4 937 946 10.1517/14712598.4.6.937 15174975 (Pubitemid 38843230)
34. Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus. Kwissa M, Amara RR, Robinson HL, Moss B, Alkan S, Jabbar A, Villinger F, Pulendran B, J Exp Med 2007 204 2733 2746 10.1084/jem.20071211 17954572 (Pubitemid 350044795)
35. Toll-like receptor 9 (TLR9) agonists in the treatment of cancer. Krieg AM, Oncogene 2008 27 161 167 10.1038/sj.onc.1210911 18176597
36. Molecular mechanims underlying anti-inflammatory phenotype of neonatal splenic macrophages. Chelvarajan L, Popa D, Liu Y, Getchell TV, Stromberg AJ, Bondada S, J Leukoc Biol 2007 82 403 416 10.1189/jlb.0107071 17495050 (Pubitemid 47230652)
37. Neonatal innate TLR-mediated responses are distinct from those of adults. Kollmann TR, Crabtree J, Rein-Weston A, Blimkie D, Thommai F, Wang XY, Lavoie PM, Furlong J, Fortuno ESr, Hajjar AM, Hawkins NR, Self SG, Wilson CB, J Immunol 2009 183 7150 7160 10.4049/jimmunol.0901481 19917677
38. Acquisition of adult-like TLR4 and TLR9 responses during the first year of life. Nguyen M, Leuridan E, Zhang T, De Wit D, Willems F, Van Damme P, Goldman M, Goriely S, PLoS One 2010 5 10407 10.1371/journal.pone.0010407 20442853
39. Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses. Nakano H, Lin KL, Yanagita M, Charbonneau C, Cook DN, Kakiuchi T, Gunn MD, Nat Immunol 2009 10 394 402 10.1038/ni.1707 19252492
40. Enhanced secretion of interferon-gamma by bovine gammadelta T cells induced by coculture with Mycobacterium bovis-infected dendritic cells: evidence for reciprocal activating signals. Price SJ, Hope JC, Immunology 2009 126 201 208 10.1111/j.1365-2567.2008.02889.x 18657206
41. Gamma delta T cells respond directly to pathogen-associated molecular patterns. Hedges JF, Lubick KJ, Jutila MA, J Immunol 2005 174 6045 6053 15879098 (Pubitemid 40663792)
42. Division of labor and cooperation between dendritic cells. Pulendran B, Nat Immunol 2006 7 699 700 10.1038/ni0706-699 16785884 (Pubitemid 43905865)